Follow us on LinkedIn


A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care

Artificial Intelligence Act

I-SCREEN's mission is to revolutionise the early detection and monitoring of Age-related Macular Degeneration (AMD) through innovative AI-driven solutions. Namely, we are committed to developing an efficient and cost-effective AI-based infrastructure tailored specifically for the early detection of AMD and monitoring disease progression.

The recent approval of the Artificial Intelligence Act by the European Parliament is particularly significant for projects like I-SCREEN. This legislation ensures safety, compliance with fundamental rights, and boosts innovation in AI applications. As we continue to develop and deploy AI-driven solutions for AMD detection and monitoring, the regulatory framework established by the Artificial Intelligence Act provides a solid foundation for ensuring the ethical and responsible use of AI in healthcare.

Explore the details of the Artificial Intelligence Act here.